Enhancement of apoptosis in salivary gland cancer cells by the combination of oral fluoropyrimidine anticancer agent (S-1) and radiation.

International journal of oncology

Volumn 25, Issue 4, 2004, Pages 905-911

  Harada, Koji ^a   Kawaguchi, Shin Ichi ^a   Supriatno, ^a   Onoue, Tomitaro ^a   Yoshida, Hideo ^a   Sato, Mitsunobu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; CASPASE; OXONIC ACID; PYRIDINE DERIVATIVE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; S 1 (COMBINATION); TEGAFUR;

APOPTOSIS; ARTICLE; CELL DIVISION; DRUG COMBINATION; DRUG EFFECT; HUMAN; METABOLISM; MULTIMODALITY CANCER THERAPY; ORAL DRUG ADMINISTRATION; PATHOLOGY; RADIATION EXPOSURE; SALIVARY GLAND TUMOR; TUMOR CELL LINE;

ADMINISTRATION, ORAL; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CASPASES; CELL DIVISION; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DRUG COMBINATIONS; HUMANS; OXONIC ACID; PYRIDINES; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SALIVARY GLAND NEOPLASMS; TEGAFUR;

EID: 16644380574     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)